Titan Pharmaceuticals Inc (TTNP)

[Rentier]

No, because they are not ready to start Schizophrenia trials yet. Risperdone is already an approved old drug. All Titan and Braeburn have to do is a phase III trial to prove efficacy with the ProNeura delivery system, they don't need to do phase I/II. Goes the same with a pain indication or any other already approved drug.

You see all sorts of drugs now with say the 'ER' edition or extended release formula or different binding agent. The company didn't have to do another Phase I/II trials just III to get new version release prove it is still effective and has the efficacy claimed.